☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC February Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Mesalazine has been accepted for mild and moderate exacerbations of ulcerative colitis and for maintenance of remission in ulcerative colitis and Crohn's disease.

Valsartan and losartan 100mg/hydrochlorothiazide 12.5mg have been accepted for the treatment of hypertension, the latter when monotherapy with either agent fails.

Glyceryl trinitrate 0.4% ointment (Rectogesic®) was rejected because the economic case was insufficiently robust to gain acceptance. This was the fourth submission to be rejected.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC February Update' by emailShare 'SMC February Update' on FacebookShare 'SMC February Update' on TwitterShare 'SMC February Update' on LinkedInShare 'SMC February Update' on reddit


One Comment to “SMC February Update”

  1. How's the medicine suiting you, sir?

    Trackback by Trusted.MD Network — February 19, 2008 #

Leave a Reply to Trusted.MD Network Cancel reply

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.